Dual Gıp And Glp1 Receptor Agonist, Antidiabetic Medication
Active Ingredient: Tirzepatide 10mg
Half-Life: 5-7 Days
Classification: Dual Gıp And Glp1 Receptor Agonist, Antidiabetic Medication
Dosage: Start Low And İncrease Gradually, Specific Dosages Adjusted Based On Treatment Response And Patient Tolerance
Acne: None
Water Retention: None
Hepatotoxicity: None
Aromatization: None
Click below to learn more about: Beljaro 10mg
